MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2023 International Congress

    Botulinum toxin treatment for focal dystonia in a Tunisian cohort

    M. Jamoussi, H. Benrhouma, M. Ben Hafsa, T. Ben Younes, Z. Miladi, H. Klaa, I. Kraoua, N. Gouider Khouja, I. Ben Youssef (Tunis, Tunisia)

    Objective: Our aim was to report the etiology, management and outcome of patients with focal dystonia. Background: Focal dystonia (FD) is characterized by involuntary muscle…
  • 2023 International Congress

    The use of contrast-enhanced ultrasonography of muscle spasticity and myofascial trigger points

    R. Bubnov (Kyiv, Ukraine)

    Objective: The aim of this study was to evaluate the relevance of contrast-enhanced ultrasound (CEUS) for evaluating MTrPs vascularity and its potential added value for…
  • 2023 International Congress

    Hyperkinetic dystonia in dyskinetic cerebral palsy responds to combined DBS stimulation in thalamus and pallidum.

    A. Zakharova, J. Maclean, T. Sanger (Orange, USA)

    Objective: To describe the response of hyperkinetic dystonia in four pediatric patients with dyskinetic CP to combined DBS stimulation in thalamus and pallidum. Background: Dystonia…
  • 2023 International Congress

    Deep Brain Stimulation Duration and Changes in Basal Ganglia Excitatory/Inhibitory Balance in Children and Young Adults with Dystonia

    T. Larsh, D. Gilbert, S. Vadivelu, S. Wu (Cincinnati, USA)

    Objective: We sought to explore associations between basal ganglia aperiodic signals and time since deep brain stimulation (DBS) implantation in children and young adults with…
  • 2023 International Congress

    Monogenic Dystonia and Deep Brain Stimulation: Single Center Experience

    V. Racki, M. Hero, E. Papic, G. Rozmaric, M. Raguz, B. Petek, B. Peterlin, D. Chudy, V. Vuletic (Rijeka, Croatia)

    Objective: The aim of this study was to retrospectively assess the efficacy of deep brain stimulation in patients with confirmed monogenic dystonia. Background: Treatment of…
  • 2023 International Congress

    Bridging the Gap between Statistical significance and Clinical Relevance: A Systematic Review of Minimum clinically important difference (MCID) thresholds of scales reported in trials of Movement Disorders

    B. Mishra, S. Pachipala, R. Rajan, A. Agarwal, MVP. Srivastava, N. Nilima, VY. Vishnu (Delhi, India)

    Objective: To provide a comprehensive review of various patient-reported outcome (PROs) used in movement disorders (MD) research and their MCID values reported in literature. Background:…
  • 2023 International Congress

    A case of idiopathic lower limb dystonia treated with combined use of botulinum toxin type A and phenol nerve block

    E. Bianchini, A. Massimiani, J. Bemporad, M. Giovannelli (Rome, Italy)

    Objective: Here we report a case of focal LLD successfully treated with combined botulinum neurotoxin type A (BoNTA) and Nerve block (NB). Background: Among focal dystonias,…
  • 2023 International Congress

    A retrospective comparison between EMG and US-guided botulinum injections for cervical dystonia

    V. Livneh, A. Socher, M. Cohen, Y. Schechter, I. Israel, T. Gurevic, G. Yahalom (Tel Aviv, Israel)

    Objective: To assess the efficacy and safety of ultrasound-guided (USg) botulinum toxin (BT) injections versus electromyography–guided (EMGg)- BT injections for cervical dystonia. Background: BT is…
  • 2023 International Congress

    Clinical presentation and evolution of isolated focal and segmental dystonia in adults – 20 years experience from a botulinum toxin clinic

    A. Vijayaraghavan, D. Divya, S. Krishnan (Trivandrum, India)

    Objective: To provide unique data on the common patterns of muscles selected for injection and the time course of benefit and weakness for BoNT injections…
  • 2023 International Congress

    Benefit of multiple incobotulinumtoxinA injections for pain reduction in adults with cervical dystonia: an analysis of pooled data

    A. Albanese, J. Wissel, W. Jost, A. Castagna, M. Althaus, G. Comes, A. Scheschonka, M. Vacchelli, H. Jinnah (Rozzano, Italy)

    Objective: To assess the long-term effects of repeated incobotulinumtoxinA (inco-A) injections on cervical dystonia (CD)-related pain in a pooled analysis of studies in adults with…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 39
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley